Detalhe da pesquisa
1.
Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial.
Lancet
; 401(10394): 2124-2137, 2023 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37302395
2.
International Society of Urological Pathology (ISUP) Gleason Grade Groups stratify outcomes in the CHHiP Phase 3 prostate radiotherapy trial.
BJU Int
; 133(2): 179-187, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37463104
3.
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Lancet
; 399(10323): 447-460, 2022 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953525
4.
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Int J Cancer
; 151(3): 422-434, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35411939
5.
4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial.
Lancet Oncol
; 22(3): 332-340, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539729
6.
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.
Lancet
; 395(10237): 1613-1626, 2020 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32580883
7.
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol
; 21(1): 162-174, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31806540
8.
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.
Lancet
; 390(10099): 1048-1060, 2017 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28779963
9.
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
Lancet Oncol
; 17(8): 1047-1060, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27339115
10.
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
Lancet Oncol
; 16(16): 1605-16, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26522334
11.
4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial.
Lancet Oncol
; 15(4): 457-63, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24572077
12.
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial.
Lancet Oncol
; 15(4): 464-73, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24581940
13.
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.
Lancet Oncol
; 15(7): 738-46, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24836273
14.
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial.
Lancet Oncol
; 13(1): 43-54, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22169269
15.
The Fraction Size Sensitivity of Late Genitourinary Toxicity: Analysis of Alpha/Beta (α/ß) Ratios in the CHHiP Trial.
Int J Radiat Oncol Biol Phys
; 115(2): 327-336, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35985457
16.
Gastrointestinal Toxicity Prediction Not Influenced by Rectal Contour or Dose-Volume Histogram Definition.
Int J Radiat Oncol Biol Phys
; 117(5): 1163-1173, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433374
17.
One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
Health Technol Assess
; 27(25): 1-176, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37991196
18.
Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials.
J Clin Oncol
; 41(4): 881-892, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36269935
19.
Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pharmacoeconomics
; 40(5): 509-518, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34664200
20.
Nonrandomized Comparison of Efficacy and Side Effects of Bicalutamide Compared With Luteinizing Hormone-Releasing Hormone (LHRH) Analogs in Combination With Radiation Therapy in the CHHiP Trial.
Int J Radiat Oncol Biol Phys
; 113(2): 305-315, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35017008